Purine Pharmaceuticals Inc.
Gillette, NJ
- UEI
- K1FBL8EVSSK6
- CAGE
- 72PP7
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 122 Sunrise Dr, Gillette, NJ 07933, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Here is a detailed, two paragraph summary on Purine Pharmaceuticals Inc.:
Purine Pharmaceuticals Inc. is a for-profit biotechnology company that conducts pharmaceutical research and development. Through federal grants from the National Institutes of Health (NIH), Purine Pharmaceuticals performs preclinical research to develop novel therapeutics for conditions like sepsis, shock, and inflammation.
Past federal awards to Purine Pharmaceuticals fall under NIH programs including the Allergy and Infectious Diseases Research program (CFDA 93.855) and the Biomedical Research and Research Training program (CFDA 93.859). As the prime recipient, Purine Pharmaceuticals has tested new drug compounds to reduce mortality, inflammation, and organ injury in mouse models of sepsis. The company also assessed a recombinant enzyme therapy to prevent organ damage after hemorrhagic shock. Research partners have included the National Institute of Allergy and Infectious Diseases and the National Institute of General Medical Sciences. In total, Purine Pharmaceuticals has received over $2 million in NIH grants since 2019 to advance the preclinical development of new treatments for sepsis, shock, and related inflammatory conditions.
Quick answers
Is Purine Pharmaceuticals Inc. registered in SAM.gov?
Yes. Purine Pharmaceuticals Inc.'s SAM.gov registration is active through February 2, 2027.
What is Purine Pharmaceuticals Inc.'s most recent federal award?
Purine Pharmaceuticals Inc.'s most recent federal grant award is Recombinant e-ntpdase for shock (R41GM151882), from National Institute of General Medical Sciences (NIH), on September 21, 2023.
On GovTribe
See Purine Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors